The UK’s National Health Service (NHS)—in partnership with biotechnology company BioNTech SE and hospitals across the country—is to grant thousands of patients with cancer in England fast-track access to trials of personalised cancer vaccines.
[News] UK NHS to enrol thousands in trials of personalised mRNA cancer vaccines
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
LATEST
Sign up for our emails
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Newsletter
Privacy Policy